argenx SE (ARGX): Price and Financial Metrics
argenx SE (ARGX)
Today's Latest Price: $161.88 USD
1.76 (1.10%)
Updated Feb 19 6:55pm
Add ARGX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ARGX Stock Summary
- The ratio of debt to operating expenses for Argenx Se is higher than it is for about merely 0.37% of US stocks.
- ARGX's price/sales ratio is 224.89; that's higher than the P/S ratio of 98.7% of US stocks.
- Over the past twelve months, ARGX has reported earnings growth of 191.72%, putting it ahead of 93.7% of US stocks in our set.
- If you're looking for stocks that are quantitatively similar to Argenx Se, a group of peers worth examining would be FATE, MOR, RARX, DNLI, and ALPN.
- ARGX's SEC filings can be seen here. And to visit Argenx Se's official web site, go to www.argenx.com.
ARGX Daily Price Range
ARGX 52-Week Price Range
ARGX Stock Price Chart More Charts
ARGX Price/Volume Stats
| Current price | $161.88 | 52-week high | $169.50 |
| Prev. close | $160.12 | 52-week low | $106.49 |
| Day low | $161.37 | Volume | 134,400 |
| Day high | $163.60 | Avg. volume | 143,133 |
| 50-day MA | $156.12 | Dividend yield | N/A |
| 200-day MA | $137.05 | Market Cap | 6.17B |
argenx SE (ARGX) Company Bio
arGEN-X N.V., a clinical-stage biopharmaceutical company, focuses on creating and developing therapeutic antibodies for the treatment of cancer and autoimmune diseases. The company was founded in 2008 and is based in Breda, Netherlands.
Top Stories View All
3 Picks Set to Soar Because of Coronavirus
Best & Worst Performing Stock Industries for February 19, 2020
Best & Worst Performing Small Cap Stocks for February 19, 2020
Best & Worst Performing Mid Cap Stocks for February 19, 2020
Best & Worst Performing Large Cap Stocks for February 19, 2020
View All Top Stories
Loading social stream, please wait...